Here, based on the mechanism underlying FAS inhibition-induced apoptosis in breast cancer cells elucidated in our current study, we found a NOX inhibitor DPI can synergistically increase the killing ability of FAS inhibitor orlistat to breast cancers in a xenograft model. Here, FAS is linked to breast carcinoma.